OSPREY MEDICAL INC - Announcements

0.00%

20.0¢

Currently unlisted.

Osprey Medical, Inc. is a commercial stage company, which is focused on protecting... Osprey Medical, Inc. is a commercial stage company, which is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. The Company’s products include AVERT, AVERT Plus, the DyeVert NG, DyeVert Plus, and DyeVert Plus EZ Systems. The AVERT Plus System reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures. The DyeVert System is a self-adjusting product that reduces the amount of contrast dye used in commonly performed heart and peripheral procedures. DyeVert interfaces with syringe-manifold systems. These technologies are available with the United States Food and Drug Administration cleared indication for dye volume reduction. Its dye reduction and monitoring technologies are designed to help physicians minimize dye usage and reduce kidney damage associated with the use of contrast media for common cardiovascular procedures.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OSP	Appendix 3B		11/12/13	315.73KB	Share
OSP	CEO Presentation		03/12/13	3.53MB	Share
OSP	AVERT System U.S. Commercialization Activities	PRICE SENSITIVE	02/12/13	79.55KB	Share
OSP	Osprey Medical Names AVERT Trial Medical Leadership	PRICE SENSITIVE	18/11/13	89.96KB	Share
OSP	Appendix 3B		13/11/13	316.99KB	Share
OSP	Appendix 3B		08/11/13	318.58KB	Share
OSP	Osprey Medical Inc - Placement Completed		08/11/13	92.39KB	Share
OSP	Becoming a substantial holder replacement notification		29/10/13	97.46KB	Share
OSP	Becoming a substantial holder		25/10/13	101.89KB	Share
OSP	Change in substantial holding		23/10/13	130.51KB	Share
OSP	Change in substantial holding		23/10/13	125.29KB	Share
OSP	Change in substantial holding		23/10/13	131.75KB	Share
OSP	Change in substantial holding		23/10/13	129.39KB	Share
OSP	Change in substantial holding		23/10/13	143.57KB	Share
OSP	Change in substantial holding		23/10/13	147.47KB	Share
OSP	Appendix 3B		23/10/13	307.92KB	Share
OSP	Issuance and Allotment under A$14 Million Private Placement		23/10/13	106.4KB	Share
OSP	Cleansing Notice		23/10/13	202.75KB	Share
OSP	Osprey Commences Diabetic Limb Efficacy Study	PRICE SENSITIVE	22/10/13	66.88KB	Share
OSP	Osprey Announces A$14 million Placement	PRICE SENSITIVE	16/10/13	97.1KB	Share
OSP	Trading Halt	PRICE SENSITIVE	14/10/13	236.72KB	Share
OSP	Appendix 3B		14/10/13	303.88KB	Share
OSP	Appendix 4C - quarterly	PRICE SENSITIVE	11/10/13	80.84KB	Share
OSP	Appendix 3B		18/09/13	303.15KB	Share
OSP	Osprey Newsletter September 2013		17/09/13	2.05MB	Share
OSP	Osprey to Commence AVERT System IDE Clinical Trial	PRICE SENSITIVE	17/09/13	81.95KB	Share
OSP	Appendix 3B		05/09/13	310.68KB	Share
OSP	Appendix 3B		28/08/13	313.2KB	Share
OSP	Half Yearly Report and Accounts	PRICE SENSITIVE	27/08/13	1.09MB	Share
OSP	US FDA Clearance for AVERT System	PRICE SENSITIVE	23/08/13	82.93KB	Share
OSP	Appendix 3B		21/08/13	331.78KB	Share
OSP	Appendix 3B		09/08/13	314.64KB	Share
OSP	Appendix 4C - quarterly	PRICE SENSITIVE	19/07/13	156.16KB	Share
OSP	Investor Newsletter - July 2013	PRICE SENSITIVE	15/07/13	4.06MB	Share
OSP	Appendix 3B		12/07/13	326.89KB	Share
OSP	Change of Address of Principal Office in US		20/06/13	77.44KB	Share
OSP	Appendix 3B		07/06/13	320.67KB	Share
OSP	Appendix 3B		16/05/13	159.46KB	Share
OSP	Appendix 3Y		16/05/13	117.64KB	Share
OSP	Appendix 3Y		16/05/13	122.47KB	Share
OSP	Results of Meeting		16/05/13	106.58KB	Share
OSP	Chairman & CEO's AGM Address		16/05/13	4.93MB	Share
OSP	Notice of Annual General Meeting/Proxy Form		26/04/13	836.52KB	Share
OSP	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/13	145.55KB	Share
OSP	Investor Newsletter April 2013		23/04/13	1.87MB	Share
OSP	Appendix 3B		17/04/13	161.27KB	Share
OSP	Annual Report to shareholders		27/03/13	2.22MB	Share
OSP	Appendix 3B		26/03/13	164.49KB	Share
OSP	Enrolment of First Patient in CINCOR IDE Clinical Study	PRICE SENSITIVE	21/03/13	90.69KB	Share
OSP	Annual Meeting of Stockholders		14/03/13	79.33KB	Share
OSP	Preliminary Final Report	PRICE SENSITIVE	26/02/13	8.02MB	Share
OSP	Release of Securities from ASX Imposed Escrow		11/02/13	215.66KB	Share
OSP	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/13	157.66KB	Share
OSP	Release of Securities from ASX Imposed Escrow		22/01/13	81.71KB	Share
OSP	Quotation of Securities - Appendix 3B		21/12/12	214.57KB	Share
OSP	Appendix 3B		18/12/12	212.34KB	Share
OSP	CEO Presentation		10/12/12	1.67MB	Share
OSP	Investor Newsletter		05/12/12	2.78MB	Share
OSP	Release of Securities from Escrow		04/12/12	81.5KB	Share
OSP	Enrolment of First Patient in Diabetic Limb Clinical Study	PRICE SENSITIVE	04/12/12	89.27KB	Share
OSP	Appendix 3X		14/11/12	80.56KB	Share
OSP	Appendix 3Z		14/11/12	88.67KB	Share
OSP	Osprey Medical Inc. appoints Mr Andy Jane to its Board		13/11/12	380.15KB	Share
OSP	Osprey CEO Presentation		31/10/12	1.99MB	Share
OSP	Osprey enhances CINCOR System	PRICE SENSITIVE	31/10/12	387.42KB	Share
OSP	Appendix 4C - quarterly	PRICE SENSITIVE	23/10/12	337.41KB	Share
OSP	Half Yearly Report and Accounts	PRICE SENSITIVE	20/08/12	206.88KB	Share
OSP	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/12	520.33KB	Share
OSP	Investor Presentation		12/07/12	1.17MB	Share
OSP	Shareholder Newsletter		11/07/12	994.03KB	Share
OSP	OSP receives A$1.1 million Victorian Government Grant	PRICE SENSITIVE	04/07/12	391.45KB	Share
OSP	Neville Mitchell appointed to Board of Directors		03/07/12	374.81KB	Share
OSP	Initial Directors Interest Notice		03/07/12	358.26KB	Share
OSP	Appendix 3B		20/06/12	129.48KB	Share
OSP	Becoming a substantial holder		04/05/12	110.71KB	Share
OSP	Becoming a substantial holder		04/05/12	110.58KB	Share
OSP	Becoming a substantial holder		04/05/12	110.88KB	Share
OSP	Becoming a substantial holder		04/05/12	111.04KB	Share
OSP	Becoming a substantial holder		04/05/12	589.05KB	Share
OSP	Becoming a substantial holder		04/05/12	603.4KB	Share
OSP	Becoming a substantial holder		04/05/12	602.63KB	Share
OSP	Osprey Medical CEO Presentation 3 May 2012		03/05/12	1.19MB	Share
OSP	Successful Listing for Osprey Medical Inc. on ASX		02/05/12	77.38KB	Share
OSP	Initial Director's Interest Notice		02/05/12	97.49KB	Share
OSP	Initial Director's Interest Notice		02/05/12	96.42KB	Share
OSP	Initial Director's Interest Notice		02/05/12	76.02KB	Share
OSP	Appendix 3B		02/05/12	127.87KB	Share
OSP	Initial Director's Interest Notice		02/05/12	76.15KB	Share
OSP	Audited Financial Statements for 31 Dec 2011		30/04/12	1.64MB	Share
OSP	Audited Financial Statements for 31 Dec 2009		30/04/12	1.44MB	Share
OSP	Audited Financial Statements for 31 Dec 2010		30/04/12	125.56KB	Share
OSP	Terms and Conditions of Warrants		30/04/12	671KB	Share
OSP	Non-Incentive Stock Option Agreement		30/04/12	468.1KB	Share
OSP	Incentive Stock Option Agreement		30/04/12	565.09KB	Share
OSP	2006 Stock Incentive Plan		30/04/12	93.5KB	Share
OSP	Securities Trading Policy		30/04/12	165.01KB	Share
OSP	Corporate Governance Statement		30/04/12	117.32KB	Share
OSP	Company's Pre Quotation Disclosure		30/04/12	88.86KB	Share
OSP	Top 20 holders		30/04/12	68.01KB	Share
OSP	Distribution Schedule		30/04/12	56.99KB	Share

OSPAppendix 3B
11/12/13		315.73KB	Share
OSPCEO Presentation
03/12/13		3.53MB	Share
OSPAVERT System U.S. Commercialization Activities
02/12/13	PRICE SENSITIVE	79.55KB	Share
OSPOsprey Medical Names AVERT Trial Medical Leadership
18/11/13	PRICE SENSITIVE	89.96KB	Share
OSPAppendix 3B
13/11/13		316.99KB	Share
OSPAppendix 3B
08/11/13		318.58KB	Share
OSPOsprey Medical Inc - Placement Completed
08/11/13		92.39KB	Share
OSPBecoming a substantial holder replacement notification
29/10/13		97.46KB	Share
OSPBecoming a substantial holder
25/10/13		101.89KB	Share
OSPChange in substantial holding
23/10/13		130.51KB	Share
OSPChange in substantial holding
23/10/13		125.29KB	Share
OSPChange in substantial holding
23/10/13		131.75KB	Share
OSPChange in substantial holding
23/10/13		129.39KB	Share
OSPChange in substantial holding
23/10/13		143.57KB	Share
OSPChange in substantial holding
23/10/13		147.47KB	Share
OSPAppendix 3B
23/10/13		307.92KB	Share
OSPIssuance and Allotment under A$14 Million Private Placement
23/10/13		106.4KB	Share
OSPCleansing Notice
23/10/13		202.75KB	Share
OSPOsprey Commences Diabetic Limb Efficacy Study
22/10/13	PRICE SENSITIVE	66.88KB	Share
OSPOsprey Announces A$14 million Placement
16/10/13	PRICE SENSITIVE	97.1KB	Share
OSPTrading Halt
14/10/13	PRICE SENSITIVE	236.72KB	Share
OSPAppendix 3B
14/10/13		303.88KB	Share
OSPAppendix 4C - quarterly
11/10/13	PRICE SENSITIVE	80.84KB	Share
OSPAppendix 3B
18/09/13		303.15KB	Share
OSPOsprey Newsletter September 2013
17/09/13		2.05MB	Share
OSPOsprey to Commence AVERT System IDE Clinical Trial
17/09/13	PRICE SENSITIVE	81.95KB	Share
OSPAppendix 3B
05/09/13		310.68KB	Share
OSPAppendix 3B
28/08/13		313.2KB	Share
OSPHalf Yearly Report and Accounts
27/08/13	PRICE SENSITIVE	1.09MB	Share
OSPUS FDA Clearance for AVERT System
23/08/13	PRICE SENSITIVE	82.93KB	Share
OSPAppendix 3B
21/08/13		331.78KB	Share
OSPAppendix 3B
09/08/13		314.64KB	Share
OSPAppendix 4C - quarterly
19/07/13	PRICE SENSITIVE	156.16KB	Share
OSPInvestor Newsletter - July 2013
15/07/13	PRICE SENSITIVE	4.06MB	Share
OSPAppendix 3B
12/07/13		326.89KB	Share
OSPChange of Address of Principal Office in US
20/06/13		77.44KB	Share
OSPAppendix 3B
07/06/13		320.67KB	Share
OSPAppendix 3B
16/05/13		159.46KB	Share
OSPAppendix 3Y
16/05/13		117.64KB	Share
OSPAppendix 3Y
16/05/13		122.47KB	Share
OSPResults of Meeting
16/05/13		106.58KB	Share
OSPChairman & CEO's AGM Address
16/05/13		4.93MB	Share
OSPNotice of Annual General Meeting/Proxy Form
26/04/13		836.52KB	Share
OSPAppendix 4C - quarterly
24/04/13	PRICE SENSITIVE	145.55KB	Share
OSPInvestor Newsletter April 2013
23/04/13		1.87MB	Share
OSPAppendix 3B
17/04/13		161.27KB	Share
OSPAnnual Report to shareholders
27/03/13		2.22MB	Share
OSPAppendix 3B
26/03/13		164.49KB	Share
OSPEnrolment of First Patient in CINCOR IDE Clinical Study
21/03/13	PRICE SENSITIVE	90.69KB	Share
OSPAnnual Meeting of Stockholders
14/03/13		79.33KB	Share
OSPPreliminary Final Report
26/02/13	PRICE SENSITIVE	8.02MB	Share
OSPRelease of Securities from ASX Imposed Escrow
11/02/13		215.66KB	Share
OSPAppendix 4C - quarterly
29/01/13	PRICE SENSITIVE	157.66KB	Share
OSPRelease of Securities from ASX Imposed Escrow
22/01/13		81.71KB	Share
OSPQuotation of Securities - Appendix 3B
21/12/12		214.57KB	Share
OSPAppendix 3B
18/12/12		212.34KB	Share
OSPCEO Presentation
10/12/12		1.67MB	Share
OSPInvestor Newsletter
05/12/12		2.78MB	Share
OSPRelease of Securities from Escrow
04/12/12		81.5KB	Share
OSPEnrolment of First Patient in Diabetic Limb Clinical Study
04/12/12	PRICE SENSITIVE	89.27KB	Share
OSPAppendix 3X
14/11/12		80.56KB	Share
OSPAppendix 3Z
14/11/12		88.67KB	Share
OSPOsprey Medical Inc. appoints Mr Andy Jane to its Board
13/11/12		380.15KB	Share
OSPOsprey CEO Presentation
31/10/12		1.99MB	Share
OSPOsprey enhances CINCOR System
31/10/12	PRICE SENSITIVE	387.42KB	Share
OSPAppendix 4C - quarterly
23/10/12	PRICE SENSITIVE	337.41KB	Share
OSPHalf Yearly Report and Accounts
20/08/12	PRICE SENSITIVE	206.88KB	Share
OSPAppendix 4C - quarterly
30/07/12	PRICE SENSITIVE	520.33KB	Share
OSPInvestor Presentation
12/07/12		1.17MB	Share
OSPShareholder Newsletter
11/07/12		994.03KB	Share
OSPOSP receives A$1.1 million Victorian Government Grant
04/07/12	PRICE SENSITIVE	391.45KB	Share
OSPNeville Mitchell appointed to Board of Directors
03/07/12		374.81KB	Share
OSPInitial Directors Interest Notice
03/07/12		358.26KB	Share
OSPAppendix 3B
20/06/12		129.48KB	Share
OSPBecoming a substantial holder
04/05/12		110.71KB	Share
OSPBecoming a substantial holder
04/05/12		110.58KB	Share
OSPBecoming a substantial holder
04/05/12		110.88KB	Share
OSPBecoming a substantial holder
04/05/12		111.04KB	Share
OSPBecoming a substantial holder
04/05/12		589.05KB	Share
OSPBecoming a substantial holder
04/05/12		603.4KB	Share
OSPBecoming a substantial holder
04/05/12		602.63KB	Share
OSPOsprey Medical CEO Presentation 3 May 2012
03/05/12		1.19MB	Share
OSPSuccessful Listing for Osprey Medical Inc. on ASX
02/05/12		77.38KB	Share
OSPInitial Director's Interest Notice
02/05/12		97.49KB	Share
OSPInitial Director's Interest Notice
02/05/12		96.42KB	Share
OSPInitial Director's Interest Notice
02/05/12		76.02KB	Share
OSPAppendix 3B
02/05/12		127.87KB	Share
OSPInitial Director's Interest Notice
02/05/12		76.15KB	Share
OSPAudited Financial Statements for 31 Dec 2011
30/04/12		1.64MB	Share
OSPAudited Financial Statements for 31 Dec 2009
30/04/12		1.44MB	Share
OSPAudited Financial Statements for 31 Dec 2010
30/04/12		125.56KB	Share
OSPTerms and Conditions of Warrants
30/04/12		671KB	Share
OSPNon-Incentive Stock Option Agreement
30/04/12		468.1KB	Share
OSPIncentive Stock Option Agreement
30/04/12		565.09KB	Share
OSP2006 Stock Incentive Plan
30/04/12		93.5KB	Share
OSPSecurities Trading Policy
30/04/12		165.01KB	Share
OSPCorporate Governance Statement
30/04/12		117.32KB	Share
OSPCompany's Pre Quotation Disclosure
30/04/12		88.86KB	Share
OSPTop 20 holders
30/04/12		68.01KB	Share
OSPDistribution Schedule
30/04/12		56.99KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

OSPREY MEDICAL INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available